North American enrollment in clinical trials is reportedly becoming an issue for regulatory approval. The clinical trials market is seeing growth and transformation, with advances in areas such as cancer treatment and the use of artificial intelligence, but some studies have paused enrollment. The situation is complex, with various efforts underway to address challenges and improve clinical trial efficiency, but the overall impact on regulatory approval is unclear.